tiprankstipranks
Wakamoto Pharmaceutical Co., Ltd. (JP:4512)
:4512
Japanese Market
4512
Wakamoto Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports
Want to see JP:4512 full AI Analyst Report?

Wakamoto Pharmaceutical Co., Ltd. (4512) Financial Statements

0 Followers

Wakamoto Pharmaceutical Co., Ltd. Financial Overview

Wakamoto Pharmaceutical Co., Ltd.'s market cap is currently ¥9.34B. The company's EPS TTM is ¥-5.12; its P/E ratio is 41.09; and it has a dividend yield of 1.06%. Wakamoto Pharmaceutical Co., Ltd. is scheduled to report earnings on May 15, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue¥ 9.91B¥ 7.79B¥ 7.74B¥ 8.66B¥ 8.38B
Gross Profit¥ 4.73B¥ 3.62B¥ 3.54B¥ 4.11B¥ 4.36B
Operating Income¥ 255.54M¥ -457.80M¥ -195.51M¥ 141.47M¥ -13.39M
EBITDA¥ 698.48M¥ 438.68M¥ 504.84M¥ 575.81M¥ 755.52M
Net Income¥ 227.22M¥ 64.44M¥ 108.96M¥ 138.26M¥ 238.54M
Balance Sheet
Cash & Short-Term Investments¥ 2.01B¥ 2.95B¥ 3.66B¥ 3.88B¥ 3.23B
Total Assets¥ 16.50B¥ 15.00B¥ 15.42B¥ 15.71B¥ 14.95B
Total Debt¥ 400.00M¥ 100.00M¥ 130.73M¥ 529.00K¥ 2.65M
Net Debt¥ -1.61B¥ -2.85B¥ -3.53B¥ -3.88B¥ -3.23B
Total Liabilities¥ 4.49B¥ 3.39B¥ 3.39B¥ 3.80B¥ 3.47B
Stockholders' Equity¥ 12.01B¥ 11.61B¥ 12.03B¥ 11.91B¥ 11.48B
Cash Flow
Free Cash Flow¥ -1.05B¥ -1.04B¥ -663.02M¥ 420.76M¥ -28.97M
Operating Cash Flow¥ -486.91M¥ -592.45M¥ -107.34M¥ 631.92M¥ 339.17M
Investing Cash Flow¥ -657.56M¥ -13.50M¥ -2.35M¥ 17.13M¥ 50.57M
Financing Cash Flow¥ 195.88M¥ -103.94M¥ -104.99M¥ -1.61M¥ -1.62M
Currency in JPY

Wakamoto Pharmaceutical Co., Ltd. Earnings and Revenue History

Income Statement >

Wakamoto Pharmaceutical Co., Ltd. Debt to Assets

Balance Sheet >

Wakamoto Pharmaceutical Co., Ltd. Cash Flow

Cash Flow >

Wakamoto Pharmaceutical Co., Ltd. Forecast EPS vs Actual EPS

Earnings >